Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;40(13):1443-1451.
doi: 10.1177/0333102420966770.

Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia

Affiliations

Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia

Pedro Augusto Sampaio Rocha-Filho et al. Cephalalgia. 2020 Nov.

Abstract

Objectives: To assess the frequency and characteristics of headache in patients with COVID-19 and whether there is an association between headache and anosmia and ageusia.

Methods: This was a cross-sectional study. Consecutive patients admitted to hospital with COVID-19, confirmed by reverse transcription polymerase chain reaction (RT-PCR) technique, were assessed by neurologists.

Results: Seventy-three patients were included in the study, 63% were male; the median age was 58 years (IQR: 47-66). Forty-seven patients (64.4%) reported headaches, which had most frequently begun on the first day of symptoms, were bilateral (94%), presenting severe intensity (53%) and a migraine phenotype (51%). Twelve patients (16.4%) presented with headache triggered by coughing. Eleven (15%) patients reported a continuous headache. Twenty-eight patients (38.4%) presented with anosmia and 29 (39.7%) with ageusia. Patients who reported hyposmia/anosmia and/or hypogeusia/ageusia experienced headache more frequently than those without these symptoms (OR: 5.39; 95% CI:1.66-17.45; logistic regression). Patients with anosmia and ageusia presented headache associated with phonophobia more often compared to those with headache without these complaints (Chi-square test; p < 0.05). Headache associated with COVID-19 presented a migraine phenotype more frequently in those experiencing previous migraine (p < 0.05).

Conclusion: Headaches associated with COVID-19 are frequent, are generally severe, diffuse, present a migraine phenotype and are associated with anosmia and ageusia.

Keywords: COVID-19; Headache; SARS-CoV-2; ageusia; anosmia; olfaction disorders.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flow chart of the study.

Similar articles

Cited by

References

    1. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol Epub ahead of print 2 July 2020. DOI: 10.1016/S1474-4422(20)30221-0. - PMC - PubMed
    1. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18–22. - PMC - PubMed
    1. Lippi G, Mattiuzzi C, Bovo C, et al. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19). Diagnosis. Epub ahead of print 2 June 2020. DOI: 10.1515/dx-2020-0048. - PubMed
    1. Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 2020; 92: 577–583. - PMC - PubMed
    1. Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3,062 COVID-19 patients: A meta-analysis. J Med Virol Epub ahead of print 2020. DOI: 10.1002/jmv.25884. - PMC - PubMed

Publication types